BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in Oncology
AssigneeCarlos Witte-Hoffmann
InventorCarlos Witte-Hoffmann
Life of this patent
Estimating the term…
Abstract
In this invention, a novel protein interaction domain is provided along with several of its variants. This domain is involved in protein-protein interactions with the Bcl-2 family of proteins. It is named BLID (Bcl2 family of proteins Like Interaction Domain). Several BLID peptides that could be useful for discovery of drugs to help fight pathological states like cancer are presented.
Claims19
A method comprising the step of applying to a cell, cell culture or tissue an isolated polypeptide consisting of one or more fragments of the amino acid sequence set forth in SEQ ID NO:
- 20, wherein said polypeptide is capable of protein-protein interaction with Bcl-2 family proteins, effective to cause apoptosis.
A method of using an isolated polypeptide consisting of one or more fragments of the amino acid sequence set forth in SEQ ID NO:
- 20, wherein said polypeptide is capable of protein-protein interaction with Bcl-2 family proteins in a protein-protein assays such as fluorescence polarization assays, Isothermal titration calorimetry (ITC) and protein microarrays including protein domain microarrays, to measure binding kinetics with members of the Bcl-2 family of proteins in order to select suitable candidates for drug development.
A method of using an isolated polypeptide consisting of one or more fragments of the amino acid sequence set forth in SEQ ID NO:
- 20, wherein said polypeptide is capable of protein-protein interaction with Bcl-2 family proteins, in a protein-protein assays such as fluorescence polarization assays, Isothermal titration calorimetry (ITC) and protein microarrays including protein domain microarrays, to measure binding kinetics with the BLID protein domain in order to select suitable candidates for drug development.
Dependencies are inferred from the claim text.